+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Barrett's esophagus: novel strategies for screening and surveillance



Barrett's esophagus: novel strategies for screening and surveillance



Therapeutic Advances in Chronic Disease 10: 2040622319837851



Barrett's esophagus is the precursor lesion for esophageal adenocarcinoma. Screening and surveillance of Barrett's esophagus are undertaken with the goal of earlier detection and lowering the mortality from esophageal adenocarcinoma. The widely used technique is standard esophagogastroduodenoscopy with biopsies per the Seattle protocol for screening and surveillance of Barrett's esophagus. Surveillance intervals vary depending on the degree of dysplasia with endoscopic eradication therapy confined to patients with Barrett's esophagus and confirmed dysplasia. In this review, we present various novel techniques for screening of Barrett's esophagus such as unsedated transnasal endoscopy, cytosponge with trefoil factor-3, balloon cytology, esophageal capsule endoscopy, liquid biopsy, electronic nose, and oral microbiome. In addition, advanced imaging techniques such as narrow band imaging, dye-based chromoendoscopy, confocal laser endomicroscopy, volumetric laser endomicroscopy, and wide-area transepithelial sampling with computer-assisted three-dimensional analysis developed for better detection of dysplasia are also reviewed.

(PDF emailed within 0-6 h: $19.90)

Accession: 066648188

Download citation: RISBibTeXText

PMID: 30937155

DOI: 10.1177/2040622319837851


Related references

Another look at Barrett's esophagus. Current thinking on screening and surveillance strategies. Postgraduate Medicine 110(3): 57-8, 61-2, 65-8, 2001

Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database. Diseases of the Esophagus 21(8): 685-689, 2008

Barrett esophagus Management and surveillance strategies. Practical Gastroenterology 18(9 SUPPL ): S24-S27, 1994

How far to go? Screening and surveillance in Barrett's esophagus. American Journal of Managed Care 7(1 Suppl): S19-S26, 2001

Screening and surveillance of Barrett's esophagus. Current Gastroenterology Reports 11(3): 195-201, 2009

Screening and surveillance for Barrett esophagus. JAMA Internal Medicine 175(2): 159-160, 2015

Surveillance and screening for Barrett esophagus and adenocarcinoma. Journal of Clinical Gastroenterology 39(4 Suppl 2): S33-S41, 2005

Screening for and surveillance of Barrett's esophagus is clinically indicated. Digestive Diseases 25(3): 197-202, 2007

Not all of Barrett's esophagus surveillance protocols are created equal: the dangers of retrospective outcome research in the treatment of Barrett's esophagus. Gastrointestinal Endoscopy 80(6): 1203, 2015

Screening and surveillance in Barrett's esophagus: a call to action. Clinical Gastroenterology and Hepatology 2(10): 861-864, 2004

Barrett's Esophagus: Diagnosis, Screening, Surveillance, and Controversies. Gut and Liver 1(2): 93-100, 2007

The field effect in Barrett's esophagus: can we use it for screening and surveillance?. Endoscopy 45(12): 989-991, 2014

Barrett's esophagus: update on screening, surveillance, and treatment. Archives of Internal Medicine 159(13): 1411-1416, 1999

Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?. Digestive Diseases and Sciences 63(8): 2094-2104, 2018

The use of optical coherence tomography in screening and surveillance of Barrett's esophagus. Clinical Gastroenterology and Hepatology 3(7 Suppl 1): S8-11, 2005